Alpha Cognition Inc. (OTCQB: ACOG) (CSE: ACOG) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today...
Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...
Not for distribution in the United States or to U.S. newswire services Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company...
Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Alpha Cognition Inc. (“Alpha” or the “Company”...
L'OCRCVM permet la reprise de la négociation - ACOG Canada NewsWire VANCOUVER, BC, le 18 nov. 2022 VANCOUVER, BC, le 18 nov. 2022 /CNW/ - Reprise des négociations pour : Société : Alpha...
IIROC Trading Resumption - ACOG Canada NewsWire VANCOUVER, BC, Nov. 18, 2022 VANCOUVER, BC, Nov. 18, 2022 /CNW/ - Trading resumes in: Company: Alpha Cognition Inc. TSX-Venture Symbol: ACOG All...
Suspension de la négociation par l'OCRCVM - ACOG Canada NewsWire VANCOUVER, BC, le 17 nov. 2022 VANCOUVER, BC, le 17 nov. 2022 /CNW/ - L'OCRCVM a suspendu la négociation des titres...
IIROC Trading Halt - ACOG Canada NewsWire VANCOUVER, BC, Nov. 17, 2022 VANCOUVER, BC, Nov. 17, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Alpha Cognition...
NOT FOR DISSEMINATION IN THE UNITED STATESOR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Alpha Cognition Inc. (“Alpha” or the “Company”...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.